Gujarat Kidney & Super Speciality Ltd
- Market Cap ₹ 899 Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E 956
- Book Value ₹
- Dividend Yield %
- ROCE 19.6 %
- ROE 16.7 %
- Face Value ₹ 2.00
Pros
Cons
- Earnings include an other income of Rs.0.70 Cr.
- Company has high debtors of 318 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | |
|---|---|---|
| 0.00 | 4.77 | |
| 0.01 | 3.20 | |
| Operating Profit | -0.01 | 1.57 |
| OPM % | 32.91% | |
| 0.00 | 0.70 | |
| Interest | 0.00 | 0.04 |
| Depreciation | 0.00 | 0.28 |
| Profit before tax | -0.01 | 1.95 |
| Tax % | 0.00% | 25.13% |
| -0.01 | 1.45 | |
| EPS in Rs | ||
| Dividend Payout % | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 9500% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 17% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | |
|---|---|---|
| Equity Capital | 0.20 | 0.20 |
| Reserves | 0.17 | 10.69 |
| 0.00 | 1.94 | |
| 3.50 | 3.99 | |
| Total Liabilities | 3.87 | 16.82 |
| 2.67 | 9.74 | |
| CWIP | 0.00 | 0.00 |
| Investments | 0.01 | 0.00 |
| 1.19 | 7.08 | |
| Total Assets | 3.87 | 16.82 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | |
|---|---|---|
| 0.00 | -2.11 | |
| 0.00 | -7.35 | |
| 0.00 | 10.63 | |
| Net Cash Flow | 0.00 | 1.17 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | |
|---|---|---|
| Debtor Days | 318.32 | |
| Inventory Days | 317.90 | |
| Days Payable | 2,825.81 | |
| Cash Conversion Cycle | -2,189.58 | |
| Working Capital Days | 114.01 | |
| ROCE % | 19.55% |
Documents
Annual reports
No data available.